Market sentiment signals for C4 Therapeutics (CCCC): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
13 analysts
Options Flow (P/C)
0.09
More calls — Bullish
Avg Consensus PT
$12
+270.6%
Highest Price Target
$30
+866.8%
Lowest Price Target
$6
+93.4%
Short Interest
33.0%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | JP Morgan | Anupam Rama— | +222.3% | $10 | Initiate | Overweight |
| Jun 1, 2026 | Evercore ISI Group | Gavin Clark-Gartner— | +286.7% | $7 → $12 | Maintained | Outperform |
